Cargando…
Neuroprotective Properties of Quinone Reductase 2 Inhibitor M-11, a 2-Mercaptobenzimidazole Derivative
The ability of NQO2 to increase the production of free radicals under enhanced generation of quinone derivatives of catecholamines is considered to be a component of neurodegenerative disease pathogenesis. The present study aimed to investigate the neuroprotective mechanisms of original NQO2 inhibit...
Autores principales: | Voronin, Mikhail V., Kadnikov, Ilya A., Zainullina, Liana F., Logvinov, Ilya O., Verbovaya, Ekaterina R., Antipova, Tatyana A., Vakhitova, Yulia V., Seredenin, Sergei B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658107/ https://www.ncbi.nlm.nih.gov/pubmed/34884863 http://dx.doi.org/10.3390/ijms222313061 |
Ejemplares similares
-
Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection
por: Voronin, Mikhail V., et al.
Publicado: (2023) -
Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson’s Disease
por: Kadnikov, Ilya A., et al.
Publicado: (2020) -
Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling
por: Vakhitova, Yulia V., et al.
Publicado: (2021) -
Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
por: Voronin, Mikhail V., et al.
Publicado: (2019) -
Chaperone Sigma1R and Antidepressant Effect
por: Voronin, Mikhail V., et al.
Publicado: (2020)